XML 22 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Noncontrolling Interest
12 Months Ended
Dec. 31, 2019
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTEREST

NOTE 16 – NONCONTROLLING INTEREST

 

As of December 31, 2019, Yu Zhou, director and former Co-Chief Executive Officer of Genexosome, who owns 40% of the equity interests of Genexosome, which is not under the Company's control. The following is a summary of noncontrolling interest activities in the years ended December 31, 2019 and 2018.

  

   Amount 
Noncontrolling interest at January 1, 2018  $(585,394)
Net loss attributable to noncontrolling interest   (278,174)
Foreign currency translation adjustment attributable to noncontrolling interest   1,368 
Noncontrolling interest at December 31, 2018   (862,200)
Noncontrolling interest deficit adjustment *   862,200 
Net loss attributable to noncontrolling interest   - 
Foreign currency translation adjustment attributable to noncontrolling interest   - 
Noncontrolling interest at December 31, 2019  $- 

 

*The noncontrolling interest holder does not have the ability to satisfy the deficit of $862,200 (See note 21).